HIV prevention and treatment clinical trials unit at UNC
Official title: University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
Funded at Univ of North Carolina Chapel Hill · NIH-11458534 · Data updated 2026-11-12
A UNC-led program coordinates HIV prevention and treatment clinical trials across multiple sites to help people with HIV and those at risk, including diverse populations in the US and abroad.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | December 1, 2025 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,417 |
| NIH project number | 3UM1AI069423-20S2 |
| Project ID | NIH-11458534 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals living with HIV (newly diagnosed, on therapy with adherence challenges, or drug-resistant HIV) and people at risk for HIV or co-infections in diverse settings.
✕Less likely to help
Some trials may not directly benefit patients who do not meet specific enrollment criteria or in regions not included in the study network.
What this research studies
This grant supports a global HIV CTU that collaborates with sites in the US, southern Africa, and Southeast Asia to advance HIV prevention and treatment. It emphasizes enrollment of people living with HIV at various stages of care, including acute infection and those with adherence challenges, as well as individuals at risk for HIV and co-infections like TB and HBV. The unit will work with four NIH clinical trial networks and include experienced site leaders across multiple countries. The program aims to accelerate promising interventions through practical, patient-facing clinical trials. The focus is on translating research findings into real-world improvements for people affected by HIV and related conditions.
Why it matters
Potential benefit: If successful, patients could gain access to cutting-edge prevention and treatment options and benefit from faster translation of research into improved care.
How similar studies have gone: Past global HIV CTUs have contributed to new prevention and treatment approaches, with ongoing trials showing feasibility and impact.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Eron, Joseph J — Univ of North Carolina Chapel Hill
- Study coordinator: Eron, Joseph J
Related research
Other NIH-funded projects on the same topics.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
Adolescent girls in Uganda: a long-term look at how money empowerment and family support affect HIV prevention, care, and mental health
A long-term study in rural Uganda will test whether an intervention that combines economic empowerment and family strengthening can help HIV-negative and HIV-affected adolescent girls move safely into young adulthood.
-
Long-term HIV prevention and mental health support for adolescent girls and young women in Uganda
A long-term program in rural Uganda tests if combining economic support and family strengthening helps teenage girls stay HIV-free and improve mental health as they grow into young adults.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.